Drawing for NOVODIAG

USPTO serial 87780313

NOVODIAG

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
PEISECKI, MARK A
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NOVODIAG?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Charles F. Reidelbach, Jr., Esq.

Charles F. Reidelbach, Jr., Esq. HIGGS FLETCHER & MACK LLP401 WEST A STREET, SUITE 2600San Diego, CA 92101UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Reagents for scientific and research use; Reagents, other than for medical use, for sale in kit form and comprising of reagents for detecting nucleic acids or other biological markers; Reagents for in-vitro use, other than for medical purposes; Diagnostic preparations and reagents for scientific and research use, for in- vitro use, and other than medical use; chemical tests for scientific and research use for detecting nucleic acids or other biological markers; chemical tests, other than for medical use for sale in kit form for detecting nucleic acids or other biological markers; chemical tests for in-vitro use, other than for medical use, for detecting nucleic acids or other biological markersACTIVE—
005Pharmaceutical and veterinary preparations for detecting nucleic acids or other biological markers from animals or their microbes; sanitary preparations for medical purposes; Medical diagnostic reagents and assays that test for the presence of pathogens and infection; medical diagnostic kits comprised of medical diagnostic reagents and assays that test for the presence of pathogens and infection; medical diagnostic reagents and assays that test body fluids for microorganisms; medical diagnostic kits comprised of medical diagnostic reagents and assays that test body fluids for microorganisms; medical diagnostic reagents for the extraction, amplification, and purification of nucleic acids; clinical medical reagents and assays for the extraction amplification, and purification of nucleic acidsACTIVE—
009Computer hardware and software for scientific, industrial and medical analysis and research purposes, namely, computer hardware and recorded software for use in in-vitro diagnostics and for detecting nucleic acids or other biological markers, in particular for the diagnosis of medical conditions in humans and animals; laboratory robotsACTIVE—
010Surgical, medical, dental and veterinary equipment and instruments for clinical diagnosis purposes, namely, laboratory equipment for use in in-vitro diagnostics or for detecting nucleic acids or other biological markers, in particular for detecting infectious diseases, for medical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Sep 12, 2022MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 12, 2022ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 11, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 9, 2022EX3GSOU EXTENSION 3 GRANTED—
Feb 9, 2022EXT3SOU EXTENSION 3 FILED—
Feb 9, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 13, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 13, 2021ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Oct 13, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 13, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 21, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 19, 2021EX2GSOU EXTENSION 2 GRANTED—
Jul 19, 2021EXT2SOU EXTENSION 2 FILED—
Jul 19, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 11, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 9, 2021EX1GSOU EXTENSION 1 GRANTED—
Feb 9, 2021EXT1SOU EXTENSION 1 FILED—
Feb 9, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 11, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 16, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 16, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 27, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 14, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 8, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 8, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 8, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 8, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 8, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 8, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 16, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 15, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 15, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 19, 2019GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Feb 19, 2019GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Feb 19, 2019CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Nov 20, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 20, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 19, 2018ALIEASSIGNED TO LIE—
Nov 6, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 8, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 8, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 8, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 2, 2018DOCKASSIGNED TO EXAMINER—
Feb 13, 2018MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED—
Feb 11, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 5, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance